🇺🇸 FDA
Pipeline program

Paclitaxel

7823

Phase 2 small_molecule completed

Quick answer

Paclitaxel for Ovarian Cancer is a Phase 2 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
CNS Pharmaceuticals
Indication
Ovarian Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials